South Korea’s Ministry of Food and Drug Safety has approved the Cyclo G6 glaucoma laser system, Iridex announced in a press release.
The Cyclo G6 is available in more than 50 countries to treat patients with a range of glaucoma disease, the release said. It uses Iridex’s MicroPulse technology.
“International expansion in the Asia-Pacific region remains a top priority for us, and we believe that Korea represents an attractive market for our G6 technology,” President and CEO of Iridex William M. Moore said in the release.
Uncategorized